21 CFR 520.1084
§ 520.1084 Grapiprant.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1084, § 520.1084 Grapiprant, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87174
- Permanent ID
ys:prov:87174@1- SHA-256
d62deef953ddc0465953a12c5501370fadd1c04d09cf07c10cb302f96637105e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each tablet contains 20, 60, or 100 milligrams (mg) grapiprant.
(b) Sponsor. See No. 058198 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—(1) Amount. Administer 0.9 mg/lb (2 mg/kg) once daily by mouth.
(2) Indications for use. For the control of pain and inflammation associated with osteoarthritis in dogs.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.